絞り込み

16576

広告

「"Goetz MP "[Author]」の検索結果

139件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

The novel function of tumor protein D54 in regulating pyruvate dehydrogenase and metformin cytotoxicity in breast cancer.

MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.

PANOPLY: Omics-Guided Drug Prioritization Method Tailored to an Individual Patient.

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction between SLC38A7 and ALPPL2.

Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy.

ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis.

Innovative Strategies: Targeting Subtypes in Metastatic Breast Cancer.

Tyrosine Phosphorylation of Mitochondrial Creatine Kinase 1 Enhances a Druggable Tumor Energy Shuttle Pathway.

ATR inhibition is a promising radiosensitizing strategy for triple negative breast cancer.

HGT-ID: an efficient and sensitive workflow to detect human-viral insertion sites using next-generation sequencing data.

Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.

Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Germline genome-wide association studies in women receiving neoadjuvant chemotherapy with or without bevacizumab.

The development of endoxifen for breast cancer.

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine.

Discovery of a glucocorticoid receptor (GR) activity signature using selective GR antagonism in ER-negative breast cancer.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Carnitine Palmitoyltransferase 1A Has a Lysine Succinyltransferase Activity.

Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and Tamoxifen Therapy.

Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
Sort by
※並べ替えは表示に時間がかかります